GSEP
MRNA icon

Golden State Equity Partners’s Moderna MRNA Stock Holding History

Golden State Equity Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-215
Closed -$10.9K – 1194
2026
Q1 		$10.9K Buy
+215
New +$10K ﹤0.01% 1269
2024
Q4 		– Sell
-761
Closed -$50.8K – 704
2024
Q3 		$50.8K Buy
+761
New +$69.9K 0.01% 533

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Golden State Equity Partners's MRNA Position: Q2 2026 in Review

Golden State Equity Partners sold out of Moderna (MRNA) in Q2 2026, closing a stake of 215 shares — an estimated $10.9K sold.

Golden State Equity Partners first reported a position in MRNA in Q3 2024 and held it in 2 quarters. The position peaked at $50.8K in Q3 2024. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Golden State Equity Partners reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Golden State Equity Partners sold 215 Moderna shares in Q2 2026, an estimated $10.9K.
  • Golden State Equity Partners first reported a position in Moderna in Q3 2024 and held it in 2 quarters.
  • Golden State Equity Partners's Moderna position peaked at $50.8K in Q3 2024.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.